Идёт
Фаза II
Казахстан
Placebo; MORF-057 · Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of 3 Active Dose Regimens of MORF-057 in Adults With Moderately to Severely Active Crohn's Disease (GARNET)